Skip to content

Insulet Corp

Insulet

PODD · NASDAQ

Healthcare

Catalog as of September 15, 2026. Not a live market feed.

Fiscal Year
2025
Revenue
$2.7B
Assets
$3.2B
SEC filing
DEF 14A
Filed
April 6, 2026

Executive Compensation

Compensation reported for Insulet’s named executive officers, including salary, stock awards, incentive compensation, other compensation, and total compensation.

Ashley McEvoy

President And Chief Executive Officer

$18.9M

Reported total · FY2025 · SCT Total as filed

Source: DEF 14A Summary Compensation Table, filed April 6, 2026.

Salary
$730K
Stock Awards
$13M
Option Awards
$3M
Incentives
$2M
Other
$139K

Historical Compensation

Ashley McEvoy total compensation, fiscal years 2025–2025.

Year-by-year total compensation
Fiscal YearSalaryTotal Compensation
2025$729,808$18,858,968

Named Executive Officers

Source information

Company
Insulet Corp
Ticker
PODD · NASDAQ
Filing type
DEF 14A
Fiscal year
2025
Filing date
April 6, 2026
SEC accession number
0001140361-26-013333

Source: U.S. Securities and Exchange Commission, DEF 14A Summary Compensation Table. View SEC filing

Related Companies